SCR 43 is a nonstatutory concurrent resolution that proclaims April 2025 as Parkinson’s Disease Awareness Month in California. The resolution does not create a new program, mandate, or funding source; instead, it uses the Legislature’s formal recognition to highlight Parkinson’s disease, its symptoms, its prevalence, and the need for research, education, caregiver support, and improved treatment options.
The measure’s findings describe Parkinson’s disease as a chronic, progressive neurological disorder and emphasize its growing public health impact in California and nationwide. It cites estimates about the number of people affected, the economic costs of the disease, the role of the California Parkinson’s Disease Registry and the broader Neurodegenerative Disease Registry, and research efforts such as the Michael J. Fox Foundation’s Parkinson’s Progression Markers Initiative. The resolution also notes the recent validation of a biomarker for Parkinson’s disease and frames that development as a major research breakthrough.
In terms of legal effect, SCR 43 does not amend the Health and Safety Code, Government Code, or any other statute. Its practical impact is symbolic and commemorative: it formally designates an awareness month and directs the Secretary of the Senate to transmit copies of the resolution for distribution. Because it is a concurrent resolution, it primarily serves to express legislative support and raise public awareness rather than alter rights, duties, or regulatory requirements for patients, providers, or state agencies.
The overall sentiment around the bill appears strongly supportive and noncontroversial. The voting history shows unanimous approval at each recorded stage, including a 36-0 Senate third reading vote, a 6-0 committee vote to place it on the consent calendar, and a 71-0 consent calendar vote in the Assembly. The absence of committee transcripts and the unanimous votes suggest broad bipartisan agreement and little to no opposition.
There is no notable policy contention reflected in the record, likely because the resolution is ceremonial rather than regulatory. The only substantive emphasis in the text is on the need for more research, education, and community support services, but no member objections or competing viewpoints are documented. The bill’s focus is public recognition of Parkinson’s disease and support for affected Californians, their families, caregivers, researchers, and medical professionals.
SCR 43 has no direct effect on California statutes or regulatory law. It is a concurrent resolution that formally proclaims April 2025 as Parkinson’s Disease Awareness Month, creating a legislative recognition rather than a legal mandate. Its practical effect is to elevate awareness of Parkinson’s disease, highlight the work of the California Parkinson’s Disease Registry and related research efforts, and encourage attention to research, treatment, and caregiver support among state officials and the public.
The sentiment around SCR 43 is uniformly positive and supportive. The bill advanced with unanimous votes in both houses and was placed on the consent calendar, indicating that legislators viewed it as a straightforward awareness resolution with broad appeal. The record shows no recorded opposition, and the tone of the findings is empathetic and advocacy-oriented, focusing on patients, caregivers, researchers, and the need for better treatments.
No meaningful contention is reflected in the bill’s history or text. Because SCR 43 is a ceremonial resolution, it does not raise fiscal, regulatory, or implementation disputes. The only issues discussed in the findings are the severity and growing prevalence of Parkinson’s disease, the need for more research and support services, and the value of registry-based data collection, but no legislator or committee record indicates disagreement with those points.